[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.87. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,033
Citations 0
Correction
November 13, 2013

Error in Figure

JAMA. 2013;310(18):1987. doi:10.1001/jama.2013.281319

In the Preliminary Communication entitled “Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics: A Randomized Clinical Trial” in the August 28, 2013, issue of JAMA (2013;210[8]:804-811 doi:10.1001/JAMA.2013.109309), the figure had an error. In the right-hand box following the randomization oval, it should have read that 25 patients received “400 mg/d of sofosbuvir.” This article has been corrected online.

×